hrcak mascot   Srce   HID

Pregledni rad

New antimicrobial drugs

N. Bradarić
I. Bradarić
I. Curić
N. Kuzmičić

Puni tekst: hrvatski, pdf (172 KB) str. 109-126 preuzimanja: 5.417* citiraj
APA 6th Edition
Bradarić, N., Bradarić, I., Curić, I. i Kuzmičić, N. (2006). Novi antimikrobni lijekovi. Infektološki glasnik, 26 (3), 109-126. Preuzeto s https://hrcak.srce.hr/12687
MLA 8th Edition
Bradarić, N., et al. "Novi antimikrobni lijekovi." Infektološki glasnik, vol. 26, br. 3, 2006, str. 109-126. https://hrcak.srce.hr/12687. Citirano 24.10.2019.
Chicago 17th Edition
Bradarić, N., I. Bradarić, I. Curić i N. Kuzmičić. "Novi antimikrobni lijekovi." Infektološki glasnik 26, br. 3 (2006): 109-126. https://hrcak.srce.hr/12687
Harvard
Bradarić, N., et al. (2006). 'Novi antimikrobni lijekovi', Infektološki glasnik, 26(3), str. 109-126. Preuzeto s: https://hrcak.srce.hr/12687 (Datum pristupa: 24.10.2019.)
Vancouver
Bradarić N, Bradarić I, Curić I, Kuzmičić N. Novi antimikrobni lijekovi. Infektološki glasnik [Internet]. 2006 [pristupljeno 24.10.2019.];26(3):109-126. Dostupno na: https://hrcak.srce.hr/12687
IEEE
N. Bradarić, I. Bradarić, I. Curić i N. Kuzmičić, "Novi antimikrobni lijekovi", Infektološki glasnik, vol.26, br. 3, str. 109-126, 2006. [Online]. Dostupno na: https://hrcak.srce.hr/12687. [Citirano: 24.10.2019.]

Sažetak
In this article we present a brief summary of new antibiotics that were registered in Republic of Croatia in period from 2000.–2005. We stated the basic pharmacokinetic characteristics of moxifloxacine, linezolide, levofloxacine, cefipime, and telitromycine. We mentioned newer antibiotics that are registered or are waiting registration in other countries around the world like: tigecycline, quinupristine/dalfopristine, daptomycine, ertapeneme, doripeneme, dalbavancine, gemifloxacine, gatifloxacine, sitafloxacine, sparfloxacine, fosfamycine, ceftizoksim alapivoksil. Finally we listed antibiotics that are currently in various stages preclinical and clinical development around the world, most of that are still coded with numbers and/or letters. For antibiotics from the last two groups we mentioned their antibiotic classes, and for all three groups we listed their clinical indications. We discussed problems that lead to a hold in antibiotic development, and the growing need for development of newer potent antibiotics as a solution for the problem of resistant bacteria more of which emerge every day. We mentioned the basic future trends that will lead to development of newer antimicrobial drugs.

Ključne riječi
Antibiotics; antimicrobial treatment; resistance

Hrčak ID: 12687

URI
https://hrcak.srce.hr/12687

[hrvatski]

Posjeta: 5.986 *